O. Dulgar Et Al. , "Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study," JOURNAL OF CHEMOTHERAPY , 2024
Dulgar, O. Et Al. 2024. Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study. JOURNAL OF CHEMOTHERAPY .
Dulgar, O., Turker, S., BAŞARAN, G., Araz, M., Sumbul, A. T., Caglayan, D., ... GÜMÜŞAY, Ö.(2024). Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study. JOURNAL OF CHEMOTHERAPY .
Dulgar, Ozgecan Et Al. "Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study," JOURNAL OF CHEMOTHERAPY , 2024
Dulgar, Ozgecan Et Al. "Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study." JOURNAL OF CHEMOTHERAPY , 2024
Dulgar, O. Et Al. (2024) . "Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study." JOURNAL OF CHEMOTHERAPY .
@article{article, author={Ozgecan Dulgar Et Al. }, title={Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study}, journal={JOURNAL OF CHEMOTHERAPY}, year=2024}